Cotrimoxazole therapy ofToxoplasma gondii encephalitis in AIDS patients

  title={Cotrimoxazole therapy ofToxoplasma gondii encephalitis in AIDS patients},
  author={A. Canessa and V. Bono and P. Leo and N. Piersantelli and A. Terragna},
  journal={European Journal of Clinical Microbiology and Infectious Diseases},
  • A. Canessa, V. Bono, +2 authors A. Terragna
  • Published 2005
  • Medicine
  • European Journal of Clinical Microbiology and Infectious Diseases
  • Twenty-four consecutive HIV-positive patients affected byToxoplasma gondii encephalitis received trimethoprim-sulfamethoxazole (cotrimoxazole) as acute-phase treatment. Two dosage regimens of cotrimoxazole were used: 40 mg/kg/day (12 patients) or 120 mg/kg/day (12 patients) of total compound (trimethoprim plus sulfamethoxazole). Clinical and radiological responses to treatment were evaluated, and the product-limit method for survival data analysis was used. Eighteen of 24 patients showed both a… CONTINUE READING
    25 Citations
    Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006.
    • 75
    • PDF
    Toxoplasmosis in HIV/AIDS Patients - A Living Legacy
    • 4
    • PDF
    Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
    • 55
    • PDF
    Trimethoprim-sulfamethoxazole revisited.
    • 171
    • PDF
    Cerebellar toxoplasmosis in HIV/AIDS: a case report.
    • 11
    • PDF


    Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole.
    • 35
    Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome.
    • 162
    Assessment of therapy for toxoplasma encephalitis. The TE Study Group.
    • H. Haverkos
    • Medicine
    • The American journal of medicine
    • 1987
    • 185
    Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
    • 20
    The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
    • 86